Thermo Fisher Scientific Showcases Large-scale Precision Medicine Research Studies in Genotyping

Share Article

In this webinar, which LabRoots will host October 25, attendees will gain a better understanding of how the recently developed Axiom Precision Medicine Research Array can be used in a wide variety of disease and therapeutic research areas.

Mark Bouzyk, Co-Founder and CSO of AKESOgen, Inc.

As more is discovered about the implications of genetic variation in 21st century medicine, the utilization of genotyping as a molecular tool both in the research and clinical setting is as important and popular as ever. This presentation will exemplify the power and precision of the Applied Biosystems™ Axiom™ Genotyping Platform in several settings.

In this webinar, which is sponsored by Thermo Fisher Scientific, participants will learn of the flexibility and accuracy of the Axiom Genotyping platform through comprehensive demonstration, as well as how it can be used to power large-scale genomic studies. They will learn about and discuss the Applied Biosystems™ PharmacoScan Solution for pharmacogenomics research and its usefulness in clinical research trials for stratifying populations.

Examples will include the use of Applied Biosystems™ Axiom™ Genotyping Arrays in the Department of Veterans Affairs’ Million Veteran Program (MVP), the use of the Applied Biosystems™ Axiom™ Precision Medicine Research Array, the use of the PharmacoScan Solution for pharmacogenetics, as well as using a unique custom array for potential dementia risk assessment.

Dr. Mark Bouzyk, co-founder and CSO of AKESOgen, Inc., will be the speaker for this event.

Bouzyk currently serves as co-founder and chief scientific officer of AKESOgen, Inc., a genomics, pharmacogenomics and biobanking company. Prior to AKESOgen, he spent five years as a faculty member in the Department of Human Genetics at Emory University. Bouzyk earned his doctorate degree in human molecular genetics from the University of Hertfordshire; his interests lie in Pharmacogenetics as well as candidate gene and genomic association studies to identify genes for both common and rare diseases.

LabRoots will host the webinar October 25, 2017, beginning at 08:00 a.m. PDT, 11:00 a.m. EDT. To learn more about this event, discover the continuing education credits available, or to register for free, click here.

For Research Use Only. Not for use in diagnostic procedures.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website